Fig. 5.

Abundance changes of representative serum metabolic and lipidomic biomarkers that differentiate the NAFLD and healthy subjects. (A) Comparison of lipids in the control and NAFLD subjects. (B) Comparison of acylcarnitines in the control and NAFLD subjects. (C) Comparison of organic acids in the control and NAFLD subjects. Bar plot represents the normalized intensity (normalized to TIC) of metabolites detected from each serum sample. Data are represented as normalized intensity ± SEM (n = 8/group). A comparison was made between the NAFLD and control subjects by Student's t-test. *, significantly different between the control and NAFLD subjects at p < 0.05; **, significantly different between the control and NAFLD subjects at p < 0.01.